Article ID Journal Published Year Pages File Type
8733748 Critical Reviews in Oncology/Hematology 2017 11 Pages PDF
Abstract
Salivary gland malignant tumor (SGMT) is a malignant disease requiring multidisciplinary approach. The rare incidence and the consequent lack of robust evidence-based medicine has called for a comprehensive update to draw recommendations for clinical practice. This paper is a summary of the XXX Head and Neck Unit guidelines regarding the management of SGMT. Recommendations include the indications for exclusive and adjuvant therapy, as well as metastatic management, for both major and minor SGMT.
Related Topics
Health Sciences Medicine and Dentistry Hematology
Authors
, , , , , , , , , , , , , ,